Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
9,38 USD | +1,79 % | -4,67 % | +15,23 % |
18/04 | Verastem Oncology anuncia cambios ejecutivos | CI |
14/03 | Verastem, Inc. Resultados del ejercicio cerrado el 31 de diciembre de 2023 | CI |
Resumen de negocios
Número de empleados: 73
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Dan Paterson
CEO | Chief Executive Officer | 63 | 01/01/11 |
Daniel Calkins
DFI | Director of Finance/CFO | 37 | 01/12/18 |
Jonathan Pachter
CTO | Chief Tech/Sci/R&D Officer | 66 | 01/07/11 |
Brian Stuglik
BRD | Director/Board Member | 64 | 02/09/17 |
Michael Crowther
PRN | Corporate Officer/Principal | - | 26/10/23 |
Corporate Officer/Principal | 67 | 19/01/17 | |
Cathy Carew
PRN | Corporate Officer/Principal | - | - |
David Mitchell
LAW | General Counsel | 67 | 26/10/23 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Eric Rowinsky
BRD | Director/Board Member | 67 | 03/05/17 |
John Johnson
BRD | Director/Board Member | 66 | 23/04/20 |
Michael Kauffman
CHM | Chairman | 60 | 26/11/12 |
Dan Paterson
CEO | Chief Executive Officer | 63 | 01/01/11 |
Paul Bunn
BRD | Director/Board Member | 79 | 24/06/21 |
Anil Kapur
BRD | Director/Board Member | 54 | 20/10/22 |
Robert Gagnon
BRD | Director/Board Member | 49 | 13/12/22 |
Karin Tollefson
BRD | Director/Board Member | 57 | 15/05/23 |
Brian Stuglik
BRD | Director/Board Member | 64 | 02/09/17 |
Director/Board Member | 57 | 15/11/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 25 307 669 | 25 163 000 ( 99,43 %) | 0 | 99,43 % |
Acción B | 0 | 1 200 000 | 0 | 0 |
Información de la empresa
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+15,23 % | 237 M | |
-2,31 % | 103 mil M | |
+0,56 % | 95,28 mil M | |
+1,69 % | 22,15 mil M | |
-17,37 % | 21,02 mil M | |
-9,30 % | 18,15 mil M | |
-41,01 % | 16,74 mil M | |
-14,85 % | 16,05 mil M | |
+3,21 % | 13,68 mil M | |
+33,54 % | 12,17 mil M |
- Bolsa de valores
- Acciones
- Acción VSTM
- Empresa Verastem, Inc.